• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.

作者信息

Xu Z H, Huang S L, Zhou H H

机构信息

Pharmacogenetics Research Institute, Hu-nan Medical University, Changsha, China.

出版信息

Zhongguo Yao Li Xue Bao. 1996 Sep;17(5):399-402.

PMID:9863158
Abstract

AIM

To determine effect of fluvoxamine (Flu) on imipramine (lmi) N-demethylation in healthy Chinese subjects.

METHODS

The pharmaco-kinetic parameters of a single oral dose of lmi (100 mg) were compared before and during 2 wk coadministration of Flu (100 mg.d-1).

RESULTS

Flu resulted in a doubling of Cmax (112 +/- 33 vs 62 +/- 22 micrograms.L-1, P < 0.01) and an increase in AUC0- infinity (3.9 +/- 1.6 vs 1.5 +/- 0.6 mg.h.L-1, P < 0.01) of lmi. The T1/2 of lmi was prolonged (39 +/- 8 vs 23 +/- 7 h, P < 0.01) due to a marked reduction in Cl0 of lmi (0.6 +/- 0.3 vs 1.3 +/- 0.6 L.h-1.kg-1, P < 0.01). The Cmax of N-demethylated metabolite desipramine (Des) of lmi was decreased (10 +/- 2 vs 18 +/- 5 micrograms.L-1, P < 0.01) and AUC0- infinity of Des was reduced by 54% (0.61 +/- 0.20 vs 1.3 +/- 0.5 mg.h.L-1, P < 0.01) during coadministration with Flu.

CONCLUSION

Flu can markedly inhibit lmi N-demethylation in Chinese young men.

摘要

相似文献

1
Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
Zhongguo Yao Li Xue Bao. 1996 Sep;17(5):399-402.
2
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.文拉法辛:体外对细胞色素P450 2D6依赖性丙咪嗪和地昔帕明代谢的抑制作用;与选定的选择性5-羟色胺再摄取抑制剂的比较研究,以及对人肝细胞色素P450 3A4、细胞色素P450 2C9和细胞色素P450 1A2的影响。
Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x.
3
Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.氟伏沙明对健康受试者体内丙咪嗪和去甲丙咪嗪药代动力学的影响。
Ther Drug Monit. 1993 Jun;15(3):243-6. doi: 10.1097/00007691-199306000-00011.
4
The effect of sertraline on the pharmacokinetics of desipramine and imipramine.舍曲林对去甲丙咪嗪和丙咪嗪药代动力学的影响。
Clin Pharmacol Ther. 1997 Aug;62(2):145-56. doi: 10.1016/S0009-9236(97)90062-X.
5
Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.酮康唑对健康受试者体内丙咪嗪和地昔帕明药代动力学的影响。
Br J Clin Pharmacol. 1997 Mar;43(3):315-8. doi: 10.1046/j.1365-2125.1997.00539.x.
6
Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.抗抑郁药相互作用与细胞色素P450系统。细胞色素P450 2D6的作用。
Clin Pharmacokinet. 1995;29 Suppl 1:10-8; discussion 18-9. doi: 10.2165/00003088-199500291-00004.
7
Interactions between sertraline and tricyclic antidepressants.舍曲林与三环类抗抑郁药之间的相互作用。
Am J Psychiatry. 1993 Jul;150(7):1125-6. doi: 10.1176/ajp.150.7.1125b.
8
Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?氟伏沙明与三环类抗抑郁药(TCAs):作为“新药”,三环类抗抑郁药与已确立的氟伏沙明相比如何?
Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:27-31.
9
Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.氟伏沙明对抑郁症患者血浆中丙咪嗪和去甲丙咪嗪浓度的影响。
Int J Clin Pharmacol Res. 1993;13(3):167-71.
10
Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.健康志愿者中丙咪嗪(托弗尼尔)包衣片的相对生物利用度。
Int J Clin Pharmacol Ther. 2001 Jun;39(6):271-6.

引用本文的文献

1
Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.健康中国受试者和欧洲受试者中CYP2C9、CYP2C19和CYP2D6底物的药代动力学
Eur J Clin Pharmacol. 2018 Mar;74(3):285-296. doi: 10.1007/s00228-017-2375-3. Epub 2017 Nov 27.
2
Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.氟伏沙明:儿童和青少年焦虑症治疗潜力综述
Paediatr Drugs. 2001;3(10):763-81. doi: 10.2165/00128072-200103100-00004.
3
Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
氟伏沙明。关于其在成人焦虑症管理中应用的最新综述。
Drugs. 2000 Oct;60(4):925-54. doi: 10.2165/00003495-200060040-00006.